Alshebremi M,Tomchuck SL,Myers JT,Kingsley DT,Eid S,Abiff M,Bonner M,Saab ST,Choi SH,Huang AY .2023 .Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation. J. Immunother. Cancer, 11(8) : 139-142.
Bai Y,Aodeng G,Ga L,Hai W,Ai J .2023 .Research Progress of Metal Anticancer Drugs. , 15(12) : 1002-1012.
Chen SJ,Wang SC,Chen YC,Cancer Pancreatic .2021 .The Immunotherapy for Colorectal Cancer, Lung Cancer. Int. J. Mol. Sci, 22(23) : 12836.
Cibotaru S,Sandu AI,Nicolescu A,Marin L A .2023 .Antitumor activity of PEGylated and TEGylated phenothiazine derivatives: Structure-activity relationship. Int. J. Mol. Sci, 24(6) : 85.
Clark MC,Stein AS .2020 .CD33 directed bispecific antibodies in acute myeloid leukemia. Best practice and research. Clinical haematology, 334 : 101224.
Dai Z,Xie B,Yang B,Chen X,Hu C,Chen Q C .2023 .KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells. Tissue Cell, 80 : 101974.
Huang L .2020 .Chemical synthesis and biological testing of PEG coupling (Lapatinib and allosteric PKI587). , : .
Carmon High P,KS High P .2023 .G protein-coupled receptor-targeting antibody-drug conjugates: Current status and future directions. Cancer Lett., 564 : 216191.
Huang M,Liu S,Song X,Zou X .2022 .Control Strategies for a Tumor-Immune System with Impulsive Drug Delivery under a Random Environment. Acta Mathematica Scientia, 42 : 1141-1159.
Lazebnik T,Aaroni N,Bunimovich-Mendrazitsky S .2021 .PDE based geometry model for BCG immunotherapy of bladder cancer. Biosystems, 200 : 104319.
Meng X,Lei Y,Zhang X,Sun K,Zhang L,Wang Z L .2021 .Cancer immunotherapy: Classification, therapeutic mechanisms and nanomaterial-based synergistic therapy. Appl. Mater. Today, 24 : 101149.
Mirian M,Hariri A,Yadollahi M,Kohandel M M .2022 .Circadian and immunity cycle talk in cancer destination: From biological aspects to in silico analysis. Cancers (Basel), 14(6) : 89-93.
Morton M,Marcu I,Levine M,Cosgrove C,Backes F,O'Malley D and Chambers L F .2023 .Evaluation of efficacy and adverse events after second immunotherapy exposure in endometrial and cervical carcinoma. Obstet, 142(2) : 360-363.
Singh S and Singh K ,Drugs Anticancer .2021 .. , 22(2) : 127-133.
Sun J,Tian Q,Liu M,Su Y,Liu X,Deng Y,Song Y Y .2021 .Evaluation of the antitumor effect and immune response of micelles modified with a polysialic acid-Dα-tocopheryl polyethylene glycol 1000 succinate conjugate. AAPS PharmSciTech, 22(7) : 223.
Underwood DJ,Bettencourt J,Jawad Z J .2022 .The manufacturing considerations of bispecific antibodies. Expert Opin. Biol. Ther, 22(8) : 1043-1065.
Von Rueden SK,Fan TM .2021 .Cancer-immunity cycle and therapeutic interventions-opportunities for including pet dogs with cancer. Front. Oncol., 11 : 773420.
Xiong RH,Yang SQ,Li JW,Shen XK,Jin LM,Chen CY,Yue YT,Yu ZC,Sun QY,Jiang W,Jiang MZ,Wang XY,Song SX,Cao D,Ye HL,Zhao LR,Huang LP,Bu L LP .2024 .Identification of immune-associated biomarker for predicting lung adenocarcinoma: Bioinformatics analysis and experiment verification of PTK6. , 15(1) : 102.
Yan X,Bai L,Qi P,Lv J,Song X,Zhang L X .2023 .Potential effects of regulating intestinal flora on immunotherapy for liver cancer. Int. J. Mol. Sci, 24(14) : 11387.
Yang H,Tan Y,Yang J,Liu Z J .2021 .Extinction and persistence of a tumor-immune model with white noise and pulsed comprehensive therapy. Math. Comput. Simul., 182 : 456-470.
Yang T,Kang L,Li D,Song Y .2023 .Immunotherapy for HER-2 positive breast cancer. Front. Oncol., 13(5) : 442-448.
Yeo SY,Bratke G,Grull H G .2022 .High intensity focused ultrasound for treatment of bone malignancies20 years of history. Cancers (Basel), 15(1) : 65-68.
Yilmaz M and Ravandi F .2020 .The potential role of Bispecific antibodies in acute myeloid leukemia. Best Pract Res Clin Haematol., 33(4) : 101218.
Zhang J,Li F,Lu K,Zhang W .2023 .Recent advances in cold atmospheric plasma for tumor therapy. Process Biochem, 131 : 77-90.